FindTrial
Sign In

The clinicopathological study of cutaneous and systemic plasmacytosis

The clinicopathological study of cutaneous and systemic plasmacytosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071026
Enrollment
Unknown
Registered
2023-04-28
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous and systemic plasmacytosis

Interventions

Cutaneous and systemic plasmacytosis:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.The clinical and histopathological features are consistent with the characteristics of cutaneous and systemic plasmacytosis. 2.The patients have clinical and pathological data available, as well as skin tissues that can be used for further research.

Exclusion criteria

Exclusion criteria: Individuals with severe mental or language disorders, or a history of drug, drug, or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
immunofixation electrophoresis;histopathology ;—

Secondary

MeasureTime frame
IgG4;Interleukin 6;immunohistochemistry;—

Countries

China

Contacts

Public ContactLin Wang

West China Hospital, Sichuan University

lkzwl@126.com+86 18980601701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026